Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medmix AGCHIX:MEDXZ -0.22%70 5-Year Yield-on-Cost % is 1.08 as of Aug. 14, 2026, which is 74% below its 10-year median of 4.18. GuruFocus rates CHIX:MEDXZ with a GF Score™ of 70/100 and a GF Value™ of CHF9.06 (Fairly Valued). The stock has 6 warning signs investors should review. Among 1,898 Industrial Products companies, Medmix AG ranks worse than 64.91% on this metric.
Medmix AG's yield on cost for the quarter that ended in Jun. 2026 was 1.08.
The historical rank and industry rank for Medmix AG's 5-Year Yield-on-Cost % or its related term are showing as below:
CHIX:MEDXz'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.08 Med: 4.18 Max: 6.33
Current: 1.08
During the past 8 years, Medmix AG's highest Yield on Cost was 6.33. The lowest was 1.08. And the median was 4.18.
CHIX:MEDXz's 5-Year Yield-on-Cost % is ranked worse than 64.91% of 1898
companies
in the Industrial Products industry
Industry Median: 1.87
vs CHIX:MEDXz: 1.08
Medmix AG (CHIX:MEDXz) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Medmix AG 5-Year Yield-on-Cost % Related Terms
CHIX:MEDXZ vs GEV, ETN, PH: 5-Year Yield-on-Cost % Comparison
For the Specialty Industrial Machinery subindustry, Medmix AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG 5-Year Yield-on-Cost % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Medmix AG's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Medmix AG is calculated as
Medmix AG (CHIX:MEDXZ) has a 5-Year Yield-on-Cost % of 1.08 as of Aug. 14, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medmix AG and its competitors. This is 74% below median its historical median of 4.18. Over the past decade, Medmix AG's 5-Year Yield-on-Cost % has ranged from 1.08 to 6.33. According to the industry distribution chart, Medmix AG ranks #1232 out of 1898 companies in the Industrial Products industry, placing it in the top 64.9%.
Is Medmix AG's 5-Year Yield-on-Cost % too high?
Medmix AG's current 5-Year Yield-on-Cost % of 1.08 is 74% below median its 10-year median of 4.18. Over the past 10 years, this metric has ranged from a low of 1.08 to a high of 6.33. The Industrial Products industry median 5-Year Yield-on-Cost % is 1.87. Medmix AG's value of 1.08 is 42.2% below this industry median. Based on the distribution chart, Medmix AG ranks #1232 out of 1898 companies in the Industrial Products industry, which is below the industry midpoint. Overall, Medmix AG has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's 5-Year Yield-on-Cost % compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #1232 out of 1898 companies for 5-Year Yield-on-Cost %. This places Medmix AG in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.87. Medmix AG's value of 1.08 is 42.2% below this benchmark. Historically, Medmix AG's own 5-Year Yield-on-Cost % has ranged from 1.08 to 6.33 over the past decade. While the company's 10-year median is 4.18 vs. the industry median of 1.87, Medmix AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for an Industrial Products company?
The median 5-Year Yield-on-Cost % among Industrial Products companies is 1.87, based on 1,898 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medmix AG's current 5-Year Yield-on-Cost % of 1.08 is 42.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medmix AG and its competitors. For the Industrial Products industry, the median 5-Year Yield-on-Cost % is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medmix AG's current 5-Year Yield-on-Cost % is 1.08, which is 74% below median its own 10-year median of 4.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Based on GuruFocus' analysis, Medmix AG (CHIX:MEDXZ) is currently considered Fairly Valued. The stock's GF Value™ is CHF9.06, compared to a current price of CHF9.15 — trading 1% above its estimated fair value. The current 5-Year Yield-on-Cost % is 1.08, which is 74% below median its 10-year median of 4.18 and 42.2% below the Industrial Products industry median of 1.87. Medmix AG's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Medmix AG (CHIX:MEDXZ), the current 5-Year Yield-on-Cost % is 1.08 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (CHIX:MEDXZ) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be overvalued.
The current stock price of CHF9.15 is trading 1% above its estimated GF Value™ of CHF9.06.
GuruFocus considers Medmix AG to be Fairly Valued.
Key valuation signals for CHIX:MEDXZ:
5-Year Yield-on-Cost %: 1.08 (74% below median its 10-year median of 4.18)
GF Value™: CHF9.06 vs. price of CHF9.15 (1% above fair value)
Industry Position: 42.2% below the Industrial Products median (#1232 of 1898)
No single metric tells the full story. See the CHIX:MEDXZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
70GF Score
Get the complete analysis for CHIX:MEDXZ
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:MEDXZ has been successfully added to your 
